All In MedTech

PMA device

Clareon Aspheric Hydrophobic Acrylic Intraocular Lens with the AutonoMe Pre- Loaded Delivery System

Alcon Laboratories, LLC · Intraocular Lens (HQL, Class III) · First FDA decision Jan 7, 2020, newest Aug 17, 2026Cataract

Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed

FDA decisions

6

PMA pathway

Device trials

6

Naming "Clareon Aspheric Hydrophobic"

MAUDE reports

940

Brand "Clareon Aspheric Hydrophobic", since 2015

PubMed studies

0

Mentioning "Clareon Aspheric Hydrophobic"

AI summary across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.

Product review deck

A slide deck reviewing Clareon Aspheric Hydrophobic Acrylic Intraocular Lens with the AutonoMe Pre- Loaded Delivery System

About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.

  • Executive summary and key facts
  • Technology
  • Clinical evidence and trials
  • Regulatory history and safety
  • Reimbursement, market and competition
  • Risks, outlook and sources

AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.

FDA decisions

The newest 6 of 6 decisions filed under this name.

3 more FDA decisions with a free account

Medicare coverage

National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.

How devices get paid for

Clinical trials

Device studies on ClinicalTrials.gov that name "Clareon Aspheric Hydrophobic", any status and sponsor, newest update first.

Open in Trial Radar
  • Alcon ResearchNot on our public-company list

    NCT06285695 · 129 participants · Start Apr 10, 2024 · Primary completion Jun 25, 2026

    Device: Clareon Toric IOL · For: Aphakia; Corneal Astigmatism

    Sites: Calgary, Canada; Concord, Canada; Oakville, Canada · 6 sites in all

  • Alcon ResearchNot on our public-company list

    NCT05852470 · 155 participants · Start May 23, 2023 · Primary completion Oct 27, 2023

    Device: Clareon Vivity/Vivity Toric Extended Vision IOL; Clareon Monofocal/Clareon Toric IOL · For: Aphakia

    Sites: Torrance, California; Fort Collins, Colorado; Bloomfield Hills, Michigan · 7 sites in all

  • Clareon Toric vs Eyhance ToricPivotal-lookingCompleted

    Alcon ResearchNot on our public-company list

    NCT05481125 · 203 participants · Start Oct 10, 2022 · Primary completion Oct 16, 2023

    Device: Clareon IOL; Clareon Toric IOL and 2 more · For: Cataract; Aphakia

    Sites: Poughkeepsie, New York; Brecksville, Ohio; Mt. Pleasant, South Carolina · 8 sites in all

3 more trials with a free account

Adverse event reports (MAUDE)

Reports received since 2015 naming the brand "Clareon Aspheric Hydrophobic", and for the whole product code for context.

This brand

940 reports: 840 malfunction, 100 injury, 0 death

Whole product code HQL

40,785 reports: 26,247 malfunction, 14,467 injury, 2 death

Newest reports for this brand

2 more reports with a free account

All reports in MAUDE Monitor

Recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

Published research

The most relevant PubMed records for "Clareon Aspheric Hydrophobic"[tiab]. The summary above synthesizes these.

PubMedGoogle ScholarLiterature search

No PubMed record mentions this device by name.

Other devices of this type

Also filed under product code HQL.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.